Fig. 5

Effects of bone density in oxyresveratrol (OR) treatment on OVX mouse model. (a) The body weight of the rat was measured weekly after the start of the experiment. It was confirmed that the weight increased in all groups except the sham group. (b) After normalization to creatine in the group treated with 10 and 20 mg/kg of OR, DPD activity was decreased, but not as much as in the ADN group (n = 5); *p < 0.05, **p < 0.01, ***p < 0.001 compared with OVX group. Error bars, standard deviations. (c) Serum TRAP enzyme activity (mean ± SD) in rats in the OVX group was compared to the OR group. The decrease was confirmed in the OR groups of 10 and 20 mg/kg. (n = 5); **p < 0.01, ***p < 0.001 compared with OVX group. Error bars, standard deviations